{
    "2021-03-25": [
        [
            {
                "time": "2021-03-24",
                "original_text": "药企营销合规，5大风险点以及应对",
                "features": {
                    "keywords": [
                        "药企",
                        "营销合规",
                        "风险点"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-24",
                "original_text": "创新生物药龙头被爆出重大利空，机构却在调高目标价？机会来了！",
                "features": {
                    "keywords": [
                        "创新生物药",
                        "龙头",
                        "重大利空",
                        "机构",
                        "目标价"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-24",
                "original_text": "医药市场竞争即将发生巨大变化",
                "features": {
                    "keywords": [
                        "医药市场",
                        "竞争",
                        "变化"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-24",
                "original_text": "医药行业发展迅猛，这些药企被看好",
                "features": {
                    "keywords": [
                        "医药行业",
                        "发展",
                        "药企"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-24",
                "original_text": "一药企被指控窃取“药王修美乐”的商业机密！诉讼纠纷",
                "features": {
                    "keywords": [
                        "药企",
                        "窃取",
                        "商业机密",
                        "诉讼纠纷"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-24",
                "original_text": "恒瑞医药现3笔大宗交易 共成交8,026.16万元",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-24",
                "original_text": "恒瑞医药：多西他赛注射液通过仿制药一致性评价",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "多西他赛注射液",
                        "仿制药一致性评价"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-24",
                "original_text": "恒瑞医药今日大宗交易成交89.25万股，成交价87.23元溢价0.0%",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "大宗交易",
                        "成交量",
                        "成交价"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-24",
                "original_text": "“研发一哥”厉害了！7大创新药合揽超50亿，57款1类新药霸屏，17个品种冲刺首仿",
                "features": {
                    "keywords": [
                        "研发一哥",
                        "创新药",
                        "首仿"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-24",
                "original_text": "抄底买什么？主力借ETF扫货创新药和有色，头号重仓股业绩快报亮眼，北向资金更是天买入逾8亿元",
                "features": {
                    "keywords": [
                        "抄底",
                        "ETF",
                        "创新药",
                        "北向资金"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "有色"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-24",
                "original_text": "A股融资融券日报：两融余额减少14.15亿元（3月24日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-24",
                "original_text": "抱团股再被抛售 机构多空分歧大",
                "features": {
                    "keywords": [
                        "抱团股",
                        "抛售",
                        "机构",
                        "多空分歧"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-24",
                "original_text": "打造全球创新体系、强化国际化人才培养，恒瑞医药国际化稳步推进",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "创新体系",
                        "国际化人才",
                        "国际化"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}